A drug commonly used to treat Type 2 diabetes abolishes the characteristic signs of nicotine withdrawal in rats and mice, according to new research.
Innovent Biologics, Inc. announced that it has entered into a licensing agreement with Eli Lilly and Company for the development and potential
AstraZeneca announced yesterday that the U.S. Food and Drug Administration (FDA) did not approve its diabetes treatment, Farxiga, for use as a
Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat
Astra Zeneca’s diabetes drug, Farxiga met primary endpoints in a large clinical study, showing a significant reduction in hospitalization rates
The U.S. Food and Drug Administration is warning patients and doctors about a rare but serious infection that has been reported with a common class
When tissue is damaged, one of the body’s first inflammatory immune-system responders are macrophages, cells which are commonly thought of as
A new once-daily oral diabetes medication, semaglutide, was better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim’s,
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: